Works matching DE "GENZYME Corp."
Results: 82
SPONSORS.
- Published in:
- Nephrology, 2006, v. 11, p. iv, doi. 10.1111/j.1440-1797.2006.00658_2.x
- Publication type:
- Article
Biotechs sue Columbia over fourth Axel patent.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 9, p. 955, doi. 10.1038/nbt0903-955
- By:
- Publication type:
- Article
News In Brief.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 9, p. 961, doi. 10.1038/nbt0903-961
- By:
- Publication type:
- Article
Internet chat damages biotechnology stocks.
- Published in:
- Nature Biotechnology, 2000, v. 18, n. 10, p. 1030, doi. 10.1038/80201
- By:
- Publication type:
- Article
Merger terminated.
- Published in:
- Nature Biotechnology, 2000, v. 18, n. 2, p. 132, doi. 10.1038/72499
- By:
- Publication type:
- Article
Genzyme acquires Cell Genesys.
- Published in:
- Nature Biotechnology, 1999, v. 17, n. 12, p. 1151, doi. 10.1038/70688
- By:
- Publication type:
- Article
Hypothetical biotechnology mega-mergers.
- Published in:
- Nature Biotechnology, 1999, v. 17, p. 8, doi. 10.1038/9082
- By:
- Publication type:
- Article
News Blast.
- Published in:
- Bio-IT World, 2006, v. 5, n. 2, p. 24
- Publication type:
- Article
Guerilla Informatics -- Genzyme Style.
- Published in:
- Bio-IT World, 2006, v. 5, n. 2, p. 12
- By:
- Publication type:
- Article
Biotech Beckons in Bonny Scotland.
- Published in:
- Bio-IT World, 2005, v. 4, n. 10, p. 46
- By:
- Publication type:
- Article
RECOMBINATION.
- Published in:
- Bio-IT World, 2003, v. 2, n. 9, p. 22
- Publication type:
- Article
Aubagio on PBS.
- Published in:
- 2014
- Publication type:
- Product Review
Adopting Solutions to Orphan Drug Shortages.
- Published in:
- U.C. Davis Law Review, 2015, v. 48, n. 5, p. 2077
- By:
- Publication type:
- Article
Sanofi-Aventis' hostile bid for Genzyme.
- Published in:
- TCE: The Chemical Engineer, 2010, n. 833, p. 11
- Publication type:
- Article
Genzyme rejects Sanofi, sells genetic testing.
- Published in:
- TCE: The Chemical Engineer, 2010, n. 832, p. 8
- Publication type:
- Article
Genzyme admits more Boston problems.
- Published in:
- TCE: The Chemical Engineer, 2009, n. 819, p. 11
- Publication type:
- Article
Vesivirus return shuts Genzyme plant.
- Published in:
- TCE: The Chemical Engineer, 2009, n. 817/818, p. 12
- Publication type:
- Article
Acknowledgements.
- Published in:
- Nephrology Dialysis Transplantation, 2007, v. 22, n. suppl_9, p. ix63, doi. 10.1093/ndt/gfm803
- Publication type:
- Article
Study Probes Best Choice of Drug to Reduce Phosphate in Patients on Dialysis.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 298, n. 17, p. 1995, doi. 10.1001/jama.298.17.1995
- By:
- Publication type:
- Article
Banking on the future: Biobanking human blood and tissue advances cancer research.
- Published in:
- 2014
- By:
- Publication type:
- Other
Legal and regulatory update.
- Published in:
- Journal of Commercial Biotechnology, 2003, v. 10, n. 1, p. 92, doi. 10.1057/palgrave.jcb.3040059
- Publication type:
- Article
New drugs and dosage forms.
- Published in:
- American Journal of Health-System Pharmacy, 2009, v. 66, n. 18, p. 1599
- Publication type:
- Article
Society News.
- Published in:
- American Journal of Sports Medicine, 2010, v. 38, n. 4, p. 842, doi. 10.1177/0363546510368053
- Publication type:
- Article
Gaucher's disease oral therapy gets nod from FDA.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 970, doi. 10.1038/nbt1014-970
- By:
- Publication type:
- Article
Markets, venture investors and big pharma interest in RNAi soars.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 3, p. 203, doi. 10.1038/nbt0314-203
- By:
- Publication type:
- Article
Shire drops 'emergency' Fabry's disease drug.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 6, p. 478, doi. 10.1038/nbt0612-478c
- By:
- Publication type:
- Article
Genzyme-Sanofi buyout is second largest biotech deal ever.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 4, p. 293, doi. 10.1038/nbt0411-293
- By:
- Publication type:
- Article
Shire's replacement enzymes validate gene activation.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 11, p. 1139, doi. 10.1038/nbt1110-1139a
- By:
- Publication type:
- Article
When patients march in.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 11, p. 1145, doi. 10.1038/nbt1110-1145
- By:
- Publication type:
- Article
Sanofi/Genzyme hostile.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 11, p. 1142, doi. 10.1038/nbt1110-1142a
- By:
- Publication type:
- Article
Genzyme resumes shipping as Sanofi-aventis hovers.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 10, p. 994, doi. 10.1038/nbt1010-994c
- By:
- Publication type:
- Article
The path less costly.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
Genzyme partners TJAB.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 7, p. 637, doi. 10.1038/nbt0710-637b
- By:
- Publication type:
- Article
FDA crackdown on Genzyme.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 5, p. 388, doi. 10.1038/nbt0510-388
- By:
- Publication type:
- Article
As Genzyme flounders, competitors and activist investors swoop in.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 1, p. 3, doi. 10.1038/nbt0110-3
- By:
- Publication type:
- Article
A third quarter improvement for biotech hiring.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 11, p. 1056, doi. 10.1038/nbt1109-1056
- By:
- Publication type:
- Article
Genzyme backs Osiris, despite Prochymal flop.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 11, p. 966, doi. 10.1038/nbt1109-966
- By:
- Publication type:
- Article
Virus stalls Genzyme plant.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 8, p. 681, doi. 10.1038/nbt0809-681a
- By:
- Publication type:
- Article
Genzyme's Lumizyme clears bioequivalence hurdles.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 8, p. 685, doi. 10.1038/nbt0809-685a
- By:
- Publication type:
- Article
Genzyme takes Campath bet.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 6, p. 498, doi. 10.1038/nbt0609-498a
- By:
- Publication type:
- Article
Osiris seals billion-dollar deal with Genzyme for cell therapy.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 2, p. 106, doi. 10.1038/nbt0209-106
- By:
- Publication type:
- Article
FDA balks at Myozyme scale-up.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 6, p. 592, doi. 10.1038/nbt0608-592
- By:
- Publication type:
- Article
Genzyme and Isis strike megadeal.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 3, p. 251, doi. 10.1038/nbt0308-251
- By:
- Publication type:
- Article
News in brief.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 2, p. 147, doi. 10.1038/nbt0208-147
- By:
- Publication type:
- Article
Alfimeprase to succeed Genentech's alteplase?
- Published in:
- Nature Biotechnology, 2006, v. 24, n. 8, p. 875, doi. 10.1038/nbt0806-875
- By:
- Publication type:
- Article
News In Brief.
- Published in:
- Nature Biotechnology, 2006, v. 24, n. 2, p. 123, doi. 10.1038/nbt0206-123
- By:
- Publication type:
- Article
Consensus recommendations.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
Announcements.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 11, p. 1322
- Publication type:
- Article
Alemtuzumab Appears Safe, Effective, Even in Poor-Prognosis Leukemia Patients.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 10, p. 1132
- Publication type:
- Article
Market watch: Upcoming market catalysts in Q4 2011.
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 10, p. 723, doi. 10.1038/nrd3564
- By:
- Publication type:
- Article